Germany will treat the use of so-called date-rape drugs like the use of a weapon — a move aimed at tougher prosecutions for sexual assault and domestic violence. The change reflects rising reports and aims to offer stronger protection to survivors.
(c) Kobby Mendez
(c) Kobby Mendez

Germany reclassifies “date-rape” drugs as weapons to strengthen justice

THE GUARDIAN

Germany will treat the use of so-called date-rape drugs like the use of a weapon — a move aimed at tougher prosecutions for sexual assault and domestic violence. The change reflects rising reports and aims to offer stronger protection to survivors.

Read Full Story

Related Posts

Most Read

A recent Carbon Brief study shows China’s carbon dioxide emissions have remained unchanged or declined for 18 straight months, thanks in part to a surge in solar (+240 GW) and wind (+61 GW) capacity and a 5% drop in transport emissions.
China’s CO₂ emissions flat or falling for 18 months — analysis finds
Scientists at TU Wien have developed a non-toxic “deep-eutectic” solvent that separates blended fabrics — like cotton-polyester mixes — within minutes. Cotton stays intact and polyester is recovered almost fully, offering a near-complete recycling method for textiles that were once nearly impossible to reclaim.
New non-toxic solvent could revolutionize mixed textile recycling
At COP30 in Belém, Brazil officially created ten new Indigenous territories, including some overlapping Amazon National Park. The move, issued via presidential decree, adds legal protection to lands of groups like the Munduruku and Guarani-Kaiowá during a summit marked by protests.
Brazil grants 10 new Indigenous territories amid COP30 tensions
Researchers at the University of Cologne have discovered a powerful antibody — 04_A06 — that neutralizes around 98.5 % of over 300 tested HIV strains. In lab experiments the antibody reduced viral load to undetectable levels — a major step toward broad-spectrum therapies for prevention and treatment worldwide.
A breakthrough in the fight against HIV: new antibody blocks nearly all variants